Rockwell Medical to buy Vantive's hemodialysis business for $125M

What's the deal? Rockwell Medical has agreed to acquire VantiveDealroom has a profile for this one. Try Dealroom →'s hemodialysis concentrates, machines, water-treatment systems, and related consumables and services for $125 million. The deal, announced November 3, 2026, includes a one-million-square-foot manufacturing campus in Medolla, Italy, and is expected to close in mid-2027.

What's the endgame? The acquisition marks Rockwell's shift from a US-focused concentrates supplier into a diversified global hemodialysis player, adding machines, water systems, and international manufacturing. The companies project combined annual revenue of $400 million to $450 million.

Why now? The purchase lets each side reshape its focus. Vantive says the sale will let it concentrate on home dialysis and critical care, while Rockwell gains scale and a broader product portfolio at once.

Chief executive Mark Strobeck called the transaction a "transformative step in Rockwell Medical's evolution," adding that it brings distribution, manufacturing, and recurring revenue "that would take years to build organically."

What could go wrong? The $125 million base price is largely seller-financed, with up to $45 million more tied to milestones. Closing is not expected until mid-2027, and Rockwell has withdrawn its 2026 guidance, leaving integration and financing as open questions.

The signal: The deal fits a wider reshaping of the dialysis sector, where incumbents like Fresenius Medical CareDealroom has a profile for this one. Try Dealroom → are leaning into home-dialysis technology and connected care. Rockwell is betting on scale and breadth instead — but the projected transformation hinges on execution over the next several years.

Read more: finance.yahoo.com

Image credit: Generated with Gemini